Ryan, you raise valid points, and I believe they will be answered shortly. The fact you point out 'second hand', is further proof of trying to bash the company. Why is this relevant? They all work the same.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025